RenovoRx(RNXT)
$1.22+0.04 (+3.39%)
RNXT
RenovoRx financials statements
$1.22
At close:+0.04 (+3.39%)
Want to see RNXT full AI Analyst Report?
RenovoRx (RNXT) Ratios
208 Followers
RenovoRx Ratios
RNXT's free cash flow for Q3 2026 was $-2.56M. For the 2026 fiscal year, RNXT's free cash flow was decreased by $-19.00K and operating cash flow was $-2.54M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.02 | 4.10 | 1.25 | 6.59 | 17.36 |
| Quick Ratio | 3.93 | 4.10 | 1.25 | 6.59 | 17.36 |
| Cash Ratio | 3.58 | 3.75 | 1.00 | 3.98 | 16.20 |
| Solvency Ratio | -4.18 | -2.42 | -2.29 | -8.97 | -6.73 |
| Operating Cash Flow Ratio | -5.59 | -4.78 | -8.73 | -8.00 | -6.31 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 5.22M | $ 4.19M | $ -3.00M | $ 6.16M | $ 15.34M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.04 | 0.06 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.04 | 0.06 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.49 | 1.81 | -0.49 | 1.18 | 1.06 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -105.46 | -174.46 | -6.57 |
| Interest Coverage Ratio | 0.00 | 0.00 | -105.52 | -174.56 | -6.80 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.05 |
| Net Debt to EBITDA | 0.61 | 0.78 | 0.10 | 0.44 | 2.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 70.88% | 100.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -994.48% | -20497.67% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -994.30% | -20497.67% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -1113.98% | -25511.63% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -994.48% | -20497.67% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -994.48% | -20497.67% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -994.48% | -20497.67% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 89.27% | 80.35% | 89.79% | 99.39% | 111.51% |
| Return on Assets (ROA) | -137.96% | -108.57% | -697.95% | -136.12% | -38.83% |
| Return on Equity (ROE) | -205.98% | -196.83% | 341.07% | -160.46% | -41.20% |
| Return on Capital Employed (ROCE) | -203.98% | -176.68% | -3916.15% | -161.45% | -36.95% |
| Return on Invested Capital (ROIC) | -200.55% | -174.82% | -3916.15% | -161.45% | -36.95% |
| Return on Tangible Assets | -137.96% | -108.57% | -697.95% | -136.12% | -38.83% |
| Earnings Yield | -37.62% | -28.94% | -21.71% | -23.24% | -7.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.08 | 1.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 1.73 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 5.56 | 0.15 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.14 | 0.01 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.19 | 0.01 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -635.71 | 365.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 45.18 | 365.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 210.96 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 891.85 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 256.14 | 365.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.31 | -0.39 | -0.50 | -0.49 | -0.33 |
| Free Cash Flow Per Share | -0.31 | -0.39 | -0.50 | -0.49 | -0.33 |
| Dividend Paid and CapEx Coverage Ratio | -5486.50 | -760.42 | 0.00 | 0.00 | -394.40 |
| Capital Expenditure Coverage Ratio | -5486.50 | -760.42 | 0.00 | 0.00 | -394.40 |
| Operating Cash Flow Coverage Ratio | -51.76 | -32.82 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -9.77 | -212.21 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -36.97% | -30.00% | -21.76% | -20.71% | -6.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.63 | -3.49 | -4.61 | -4.30 | -13.68 |
| Price-to-Sales (P/S) Ratio | 26.43 | 708.18 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 5.47 | 6.80 | -15.71 | 6.90 | 5.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.70 | -3.33 | -4.59 | -4.83 | -14.58 |
| Price-to-Operating Cash Flow Ratio | -2.71 | -3.34 | -4.59 | -4.83 | -14.62 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | 0.13 | 0.62 | -0.12 | -0.23 |
| Enterprise Value Multiple | -2.05 | -2.67 | -4.03 | -3.84 | -13.01 |
| Enterprise Value | 22.87M | 23.58M | 45.96M | 38.15M | 71.29M |
| EV to EBITDA | -2.05 | -2.67 | -4.03 | -3.84 | -13.01 |
| EV to Sales | 20.37 | 548.27 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.08 | -2.58 | -4.48 | -4.33 | -12.02 |
| EV to Operating Cash Flow | -2.08 | -2.58 | -4.48 | -4.33 | -12.05 |
| Tangible Book Value Per Share | 0.15 | 0.19 | -0.15 | 0.34 | 0.86 |
| Shareholders’ Equity Per Share | 0.15 | 0.19 | -0.15 | 0.34 | 0.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.32 | -0.37 | -0.50 | -0.55 | -0.35 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.90 | 0.99 | 1.15 |
| Research & Development to Revenue | 5.58 | 140.12 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 6.27 | 116.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 1.13 | 27.30 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.98 | 1.04 | 1.00 | 0.89 | 0.94 |
Currency in USD
